$32.32
+0.85 (+2.70%)
Performance
1D
—
1W
—
1M
—
3M
+18.48%
6M
+43.77%
1Y
+77.19%
YTD
+19.09%
Open$31.71
Previous Close$31.47
Day High$32.47
Day Low$30.91
52W High$36.44
52W Low$15.35
Volume—
Avg Volume2.32M
Market Cap3.23B
P/E Ratio—
EPS$-0.97
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$28.48
Above
SMA 200
$22.69
Above
RSI (14)
44
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
25 analysts
Price Target
+92.0% upside
Current
$32.32
$32.32
Target
$62.07
$62.07
$37.88
$62.07 avg
$80.69
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 148.81M | 112.84M | 476.44M |
| Net Income | -85,185,002 | -58,133,531 | -46,993,180 |
| Profit Margin | -57.2% | -54.4% | -9.9% |
| EBITDA | -384,659,578 | -277,090,232 | -41,088,618 |
| Free Cash Flow | — | — | -33,034,013 |
| Rev Growth | +31.9% | +31.9% | -6.6% |
| Debt/Equity | — | — | 0.22 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |